
Sign up to save your podcasts
Or


Please listen in as Drs. Piltin, van Akkooi, and Hyngstrom discuss relevant clinical trial presentations from ASCO 2024 annual meeting and their impressions on the implications for surgical oncologists. Abstracts results discussed include the neoadjuvant NADINA and PIVOTAL trials as well as an initial report on upfront TIL therapy for stage IV patients.
By Society of Surgical Oncology5
1111 ratings
Please listen in as Drs. Piltin, van Akkooi, and Hyngstrom discuss relevant clinical trial presentations from ASCO 2024 annual meeting and their impressions on the implications for surgical oncologists. Abstracts results discussed include the neoadjuvant NADINA and PIVOTAL trials as well as an initial report on upfront TIL therapy for stage IV patients.

32,129 Listeners

30,646 Listeners

320 Listeners

495 Listeners

1,315 Listeners

87,299 Listeners

2,440 Listeners

112,539 Listeners

24,677 Listeners

56,431 Listeners

9,194 Listeners

14,397 Listeners

9 Listeners

6,366 Listeners

4,550 Listeners